If Xana performs similar to existing treatments but with less side effects then there could be interest.
Time will tell but unlikely there is an offer to be expected anytime soon.
GLTA
- Forums
- ASX - By Stock
- [INTERVIEW] Actinogen Medical reveals XanaCIDD phase 2a trials
ACW
actinogen medical limited
Add to My Watchlist
4.76%
!
2.2¢

If Xana performs similar to existing treatments but with less...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $69.89M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.1¢ | $25.07K | 1.166M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1912322 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1275051 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1912322 | 0.021 |
12 | 6710750 | 0.020 |
19 | 4493392 | 0.019 |
11 | 2679332 | 0.018 |
6 | 4292542 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 1275051 | 7 |
0.023 | 2084880 | 5 |
0.024 | 544837 | 5 |
0.025 | 1804667 | 4 |
0.026 | 1594422 | 5 |
Last trade - 12.05pm 25/06/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |